Skip to main content

Table 1 Univariate analysis for clinical profiles of CSVD burdenlow and CSVD burdenhigh groups

From: Left ventricular ejection fraction and right atrial diameter are associated with deep regional CBF in arteriosclerotic cerebral small vessel disease

 

CSVD burdenlow

n = 61

CSVD burdenhigh

n = 42

P

Demographics

 Age, y

61.53 ± 10.71

65.97 ± 13.23

0.063

 Male, n (%)

35 (57.4%)

29 (69.0%)

0.230

 Smoking, n (%)

19 (31.1%)

10 (23.8%)

0.416

 Alcohol Drinking, n (%)

5 (8.2%)

0 (0.0%)

0.151

 BMI

23.04 ± 3.40

24.46 ± 3.23

0.054

Medical History, n (%)

 Hypertension

33 (54.1%)

38 (90.5%)

< 0 .001

 Impaired Fasting Glucose

1 (1.6%)

1 (2.4%)

1.000

 Impaired Glucose Tolerance

4 (6.6%)

3 (7.1%)

1.000

 Diabetes Mellitus

10 (16.4%)

16 (38.1%)

0.013

 Hyperlipidemia

37 (60.7%)

25 (59.5%)

0.908

 Atrial Fibrillation

1 (1.6%)

1 (2.4%)

1.000

 Previous myocardial infarction

2 (3.3%)

4 (9.5%)

0.184

 Symptomatic Stroke

27 (44.3%)

28 (66.7%)

0.025

Medication History, n (%)

 Antiplatelet therapy

7 (11.5%)

5 (11.9%)

1.000

 Statins

5 (8.2%)

6 (14.3%)

0.510

 Antihypertensive Drugs

18 (29.5%)

25 (59.5%)

0.002

 Antidiabetic Drugs

8 (13.1%)

11 (26.2%)

0.930

Metabolic Variablesa

 Fasting Glucose (mmol/L)

5.08 (1.16)

5.41 (1.03)

0.024

 HbA1c (%)

5.60 (0.67)

5.85 (0.80)

0.493

 Total Cholesterol (mmol/L)

4.82 ± 1.17

4.48 ± 1.37

0.434

 Triglyceride (mmol/L)

1.32 (0.67)

1.28 (0.93)

0.511

 HDL-C (mmol/L)

1.20 ± 0.32

1.13 ± 0.33

0.365

 LDL-C (mmol/L)

3.03 ± 0.92

2.71 ± 1.04

0.400

 ApoA1 (g/L)

1.32 ± 0.26

1.30 ± 0.26

0.887

 ApoB 100 (g/L)

0.98 (0.42)

0.89 (0.53)

0.430

 Lp(a) (mg/L)

146.50 (273.00)

137.50 (181.75)

0.957

 Homocysteine (μmol/L)

13.21 (6.63)

14.44 (8.40)

0.653

 Vitamin B1 (nmol/L)

67.28 (38.04)

68.69 (27.82)

0.407

 Vitamin B6(μmol/L)

19.45 (8.02)

19.26 (7.57)

0.957

 Vitamin B12(pg/mL)

248.27 (70.93)

239.08 (77.11)

0.330

 25-(OH) Vitamin D (nmol/L)

66.90 ± 19.42

62.11 ± 18.15

0.154

 eGFR (ml/min/1.73m2)

90.45 (19.18)

77.79 (34.07)

0.039

Intima Media Thickness (mm)

0.870 ± 0.166

0.875 ± 0.170

0.896

Echocardiographic Parameters

 LAD (mm)

30.76 ± 3.45

32.40 ± 3.38

0.036

 LVEDV (ml)

90.58 ± 19.24

96.16 ± 17.03

0.179

 RVD (mm)

20.07 ± 3.49

21.06 ± 2.81

0.172

 RAD (mm)

41.26 ± 4.94

41.86 ± 4.31

0.571

 LVFS (%)

37.89 ± 3.47

37.46 ± 4.53

0.626

 E/A Ratio

0.86 ± 0.30

0.76 ± 0.22

0.080

 LVEF (%)

67.91 ± 4.69

67.26 ± 5.49

0.654

  1. aResults were presented as mean ± SD for normally distributed continuous variables or median (interquartile range, IQR) for skewedly distributed continuous variables
  2. Abbreviations: BMI body mass index, HbA1c glycated haemoglobin A1c, LDL-C low density lipoprotein-cholesterol, HDL-C high density lipoprotein-cholesterol, ApoA1 apolipoprotein A1, ApoB100 apolipoprotein B100, Lp(a) lipoprotein (a), eGFR estimated glomerular filtration rate, LAD left atrial diameter, LVEDV left ventricular end-diastolic volume, RVD right ventricular diameter, RAD right atrial diameter, LVFS left ventricular fraction shortening, E/A ratio [transmitral early-diastolic peak velocity wave (E wave)]/ [transmitral atrial wave velocity (A wave)] ratio, LVEF left ventricular ejection fraction